India's Hikal Climbs after US FDA completes audit with zero observations

Hikal

15/05/2023 06:50

** Shares of Hikal Ltd  HIKA.NS  rise as much as 4.24% to
310.70 rupees
    ** Co says U.S. Food and Drug Administration concludes its
pre-approval inspection of its facility in Gujarat with 'zero
483 observations'  urn:newsml:reuters.com:*:nFWN37B04F
    ** Trading volume is ~578,000 shares as of 11:14 a.m. IST,
more than twice the 30-day avg - Refinitiv data
    
 
 ($1 = 81.7800 Indian rupees)

 (Reporting by Bharath Rajeswaran in Bengaluru)
 ((bharath.rajeswaran@thomsonreuters.com; +91 9769003463))